Patient recruitment completed in Tourette syndrome study
Research has demonstrated a strong safety prolife and reduced tics among participants
Read MoreResearch has demonstrated a strong safety prolife and reduced tics among participants
Read MoreVirus can be lethal to humans and its spread is likely to accelerate this winter
Read MoreAgreement will be key to building a pan-European market access practice
Read MoreDIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing
Read MoreDevelopment will boost life sciences sector by delivering significant lab space in Cambridge
Read MorePharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
